Financial HealthMilestone Scientific ended 4Q with $3.3 million in cash and no debt, expressing optimism for future growth opportunities.
Healthcare System AccessThe CompuFlo system received favorable Medicare Part B payment determination and a Federal Supply Schedule contract, which provides access to key US government healthcare facilities, both of which should help drive adoption and utilization of the device.
Leadership And StrategyThe appointment of Eric Hines as CEO is seen positively, as he is investing in current CompuFlo users before expanding into more regions, preparing for more successful commercialization.